J. Jacobs et al., EFFECT OF ARSENITE ON INDUCTION OF CYP1A AND CYP2H IN PRIMARY CULTURES OF CHICK HEPATOCYTES, Toxicology and applied pharmacology, 150(2), 1998, pp. 376-382
In earlier studies, treatment with sodium arsenite was shown to decrea
se total hepatic CYP in rats. A concomitant increase in heme oxygenase
, the rate-limiting step in heme degradation to biliverdin, was consid
ered responsible for the decrease in CYP. Here we investigated the eff
ect of sodium arsenite on induction of CYP2H, CYP1A, and heme oxygenas
e in primary cultures of chicken embryo hepatocytes. When added simult
aneously with inducer, arsenite inhibited phenobarbital-mediated incre
ases in CYP2H and 3-methylcholanthrene-mediated increases in CYP1A, as
measured enzymatically and immunochemically. Near maximal decreases w
ere observed in these forms of CYP at a concentration of 2.5 mu M sodi
um arsenite. The concentration-dependent decreases in CYP2H and CYP1A
by sodium arsenite were concomitant with increases in heme oxygenase.
Sodium arsenite was not toxic at concentrations as high as 10 mu M, as
indicated by protein synthesis and the reduction of MTT by intact cel
ls. Sodium arsenite had no effect on induction of CYP2H1 mRNA, suggest
ing that the decreases in this form of CYP occurred post-transcription
ally. Treatment of cells with tin mesoporphyrin (SnMeso), an inhibitor
of heme oxygenase, resulted in inhibition of arsenite-induced heme ox
ygenase. However, SnMeso did not alter the effect of arsenite to preve
nt phenobarbital-mediated increases in CYP2H protein. SnMeso alone inh
ibited phenobarbital-mediated increases in CYP2H, Inclusion of 2 or 5
mu M exogenous heme with arsenite did not prevent the arsenite-mediate
d decrease in CYP2H. Combined treatment with heme and phenobarbital in
duced heme oxygenase to the same extent as treatment with heme, arseni
te, and phenobarbital. However, CYP2H activity was decreased only when
the treatment included arsenite. These results suggest that elevated
levels of heme oxygenase alone are not responsible for arsenite-mediat
ed decreases in CYP2H. (C) 1998 Academic Press.